Gert Mayer

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe

Kitty J. Jager, Anneke Kramer, Nicholas C Chesnaye et al. · Kidney International · 2020 · 502 citations · Full text

Medicine, Geriatric Medicine, Nephrology +9

Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Iain C. Macdougall, Andreas J. Bircher, Kai‐Uwe Eckardt et al. · Kidney International · 2016 · 475 citations · Full text

Medicine, Hematology, Nephrology +17

Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease

Hiddo J.L. Heerspink, Paul Perco, Skander Mulder et al. · Diabetologia · 2019 · 453 citations · Full text

Medicine, Molecular Biology, Pharmacology +17

Association of the COVID-19 pandemic with Internet Search Volumes: A Google TrendsTM Analysis

Maria Effenberger, Andreas Kronbichler, Jae Il Shin et al. · International Journal of Infectious Diseases · 2020 · 306 citations · Full text

Veterinary Medicine, Infectious Diseases, Disease Surveillance +15